Cargando…
Combined HPV 16 E2 and L1 methylation predict response to treatment with cidofovir and imiquimod in patients with vulval intraepithelial neoplasia
BACKGROUND: Topical cidofovir and imiquimod can effectively treat approximately 55% of patients with vulval intraepithelial neoplasia (VIN), thus avoiding the need for surgery. Human papillomavirus (HPV) [Formula: see text] gene methylation predicts response to treatment but a methylation measuremen...
Autores principales: | Hurt, Christopher Nicholas, Nedjai, Belinda, Alvarez-Mendoza, Carlos, Powell, Ned, Tristram, Amanda, Jones, Sadie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661315/ https://www.ncbi.nlm.nih.gov/pubmed/35912731 http://dx.doi.org/10.3233/CBM-210448 |
Ejemplares similares
-
Recurrence of vulval intraepithelial neoplasia following treatment with cidofovir or imiquimod: results from a multicentre, randomised, phase II trial (RT3VIN)
por: Hurt, CN, et al.
Publicado: (2018) -
Phase II trial of imiquimod and HPV therapeutic vaccination in patients with vulval intraepithelial neoplasia
por: Daayana, S, et al.
Publicado: (2010) -
AKT1 Loss Correlates with Episomal HPV16 in Vulval Intraepithelial Neoplasia
por: Ekeowa-Anderson, Arucha L., et al.
Publicado: (2012) -
p53 codon 72 polymorphism in vulval cancer and vulval intraepithelial neoplasia
por: Rosenthal, A N, et al.
Publicado: (2000) -
Immunohistochemical analysis of p53 in vulval intraepithelial neoplasia and vulval squamous cell carcinoma
por: Rosenthal, A N, et al.
Publicado: (2003)